Novo’s bid uses an unusual structure allowing Metsera investors to get most of the money upfront when the deal is signed.

Eli Lilly hiked its outlook as sales soared for its popular weight-loss drugs Zepbound and Mounjaro.  The company also recently announced a partnership with Walmart that will expand access to Zepbound ...

Shares of Danish rival Novo Nordisk slipped after it sought to snatch Pfizer target Metsera from the American drug giant's arms. Novo launched an unsolicited bid valued at up to $9 billion for obesity ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.

Eli Lilly reported strong earnings and raised guidance. Read more on what could be next for this biotech giant.

A $1 million Central Indiana Food Relief Fund has been launched to address the upcoming cuts to federal SNAP benefits due to ...

Roblox posted a wider third-quarter loss but boosted its revenue forecast for the year as a pair of videogaming crazes generated robust top-line growth. Fox logged higher revenue in its fiscal first ...

NEW YORK (AP) — The U.S. stock market is drifting around its record heights on Thursday, as Wall Street sifts through mixed developments on everything from the U.S.-China trade war to profits for Big ...

The restaurant chain posted a drop in net income and quarterly revenue missed forecasts. Chipotle said economic strains were ...

In parallel with mazisotine’s shelving, Lilly added a phase 1 NaV1.8 inhibitor from its SiteOne Therapeutics acquisition to ...